Geode Capital Management, LLC Zentalis Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,292,100 shares of ZNTL stock, worth $4.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,292,100

Previous 1,334,459 3.17%

Holding current value

$4.48 Million

Previous $5.46 Million 13.1%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.9 - $4.57 $122,841 - $193,580	-42,359 Reduced 3.17%	1,292,100 $4.74 Million
Q2 2024 Aug 09, 2024	BUY	$4.09 - $16.13 $131,787 - $519,740	32,222 Added 2.47%	1,334,459 $5.46 Million
Q1 2024 May 13, 2024	BUY	$10.83 - $16.49 $525,255 - $799,764	48,500 Added 3.87%	1,302,237 $20.5 Million
Q4 2023 Feb 13, 2024	BUY	$9.84 - $20.13 $658,296 - $1.35 Million	66,900 Added 5.64%	1,253,737 $19 Million
Q3 2023 Nov 13, 2023	BUY	$19.63 - $28.29 $2.34 Million - $3.37 Million	119,236 Added 11.17%	1,186,837 $23.8 Million
Q2 2023 Aug 11, 2023	BUY	$17.41 - $30.05 $2.99 Million - $5.16 Million	171,676 Added 19.16%	1,067,601 $30.1 Million
Q1 2023 May 15, 2023	BUY	$16.14 - $24.94 $624,747 - $965,377	38,708 Added 4.52%	895,925 $15.4 Million
Q4 2022 Feb 13, 2023	BUY	$18.07 - $25.6 $379,596 - $537,779	21,007 Added 2.51%	857,217 $17.3 Million
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $1.11 Million - $1.74 Million	54,766 Added 7.01%	836,210 $18.1 Million
Q2 2022 Aug 12, 2022	BUY	$17.91 - $52.25 $2.07 Million - $6.03 Million	115,380 Added 17.32%	781,444 $22 Million
Q1 2022 May 13, 2022	BUY	$41.58 - $80.89 $201,787 - $392,559	4,853 Added 0.73%	666,064 $30.7 Million
Q4 2021 Feb 11, 2022	BUY	$66.92 - $84.79 $1.24 Million - $1.57 Million	18,557 Added 2.89%	661,211 $55.6 Million
Q3 2021 Nov 12, 2021	BUY	$46.83 - $73.5 $9.31 Million - $14.6 Million	198,889 Added 44.82%	642,654 $42.8 Million
Q2 2021 Aug 13, 2021	BUY	$37.41 - $62.25 $2.88 Million - $4.79 Million	76,925 Added 20.97%	443,765 $23.6 Million
Q1 2021 May 12, 2021	BUY	$35.69 - $52.72 $1.25 Million - $1.85 Million	35,051 Added 10.56%	366,840 $15.9 Million
Q4 2020 Feb 12, 2021	BUY	$31.71 - $57.97 $4.77 Million - $8.72 Million	150,342 Added 82.86%	331,789 $17.2 Million
Q3 2020 Nov 13, 2020	BUY	$27.03 - $47.97 $516,597 - $916,802	19,112 Added 11.77%	181,447 $5.93 Million
Q2 2020 Aug 13, 2020	BUY	$23.2 - $54.8 $3.77 Million - $8.9 Million	162,335 New	162,335 $7.8 Million

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

68M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $198M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Zentalis Pharmaceuticals, Inc. Transaction History